Drug Design Evolution
Vijay discusses the transformative role of machine learning in drug design, emphasizing a shift from serendipitous discoveries to a more engineered approach. While advancements in AI are promising, the biotech landscape presents challenges as many low-hanging fruits have already been addressed. Exciting developments in AI for clinical trials and precision medicine are on the horizon, aiming to enhance care delivery through data science.In this clip
From this podcast
Raising Health
AI + a16z with Vijay Pande
Related Questions
Can artificial intelligence and machine learning revolutionize medicine as discussed in the episodes The AI Healthcare Revolution: What You Need to Know | Dr. Vijay Pande and Daisy Wolf and Engineering Biology Revolution?
Can artificial intelligence and machine learning revolutionize medicine as discussed in the episode AI and Actionable Insights for Drug Development with Daphne Koller and the clip AI in Drug Discovery?
How is technology changing startups in the context of the episodes Adapting Biopharma to AI with Greg Meyers and AI in Drug Discovery?